CHLORDIAZEPOXIDE MICROINJECTED INTO THE REGION OF THE DORSAL RAPHE NUCLEUS ELIMINATES THE INTERFERENCE WITH ESCAPE RESPONDING PRODUCED BY INESCAPABLE SHOCK WHETHER ADMINISTERED BEFORE INESCAPABLE SHOCK OR ESCAPE TESTING
Sf. Maier et al., CHLORDIAZEPOXIDE MICROINJECTED INTO THE REGION OF THE DORSAL RAPHE NUCLEUS ELIMINATES THE INTERFERENCE WITH ESCAPE RESPONDING PRODUCED BY INESCAPABLE SHOCK WHETHER ADMINISTERED BEFORE INESCAPABLE SHOCK OR ESCAPE TESTING, Behavioral neuroscience, 108(1), 1994, pp. 121-130
Systemic administration of benzodiazepines before exposure to inescapa
ble shock (IS) blocks the enhanced fear conditioning and escape learni
ng deficits that follow exposure to IS, whereas administration before
the subsequent behavioral testing eliminates the enhanced fear but not
the interference with escape. The failure of benzodiazepines to reduc
e the IS-produced escape learning deficit when given before testing is
inconsistent with a recent proposal that interference with escape is
mediated by an IS-induced sensitization of dorsal raphe nucleus (DRN)
activity. The present experiments demonstrate that chlordiazepoxide wi
ll block both the enhancement of fear and interference with escape res
ponding when given before either IS or testing if microinjected in the
region of the DRN. This suggests that systemic benzodiazepines fail t
o block escape deficits when given before testing because action at a
site distant from the DRN counters the effect of the drug at the DRN.